When you witness what our herbal compounds can do, you will understand their profit potential and gain confidence in their effectiveness. Request some samples. We are poised to conquer huge markets once clinical trials receive funding. Basic safely and effectiveness can be demonstrated in a single experiment involving animals exposed to a relatively inert form of bovine spongiform encephalopathy (Mad Cow) prion and autopsying their brains after Grazoph treatment.

Our products are far safer and far more effective than anything currently on the market. Because these products are quite safe and easy to use with few drug interactions, we envision the day when they can be sold over the counter to millions of average people concerned about healthy living.

We have done the hard part. We have invented, refined and performed extensive informal testing on these products. Now is the time for capitalization. Are you visionary enough to proceed with this extraordinary profit opportunity? We are currently offering a 25 times reward for investing in our company. A minimum investment of $2,500 will be returned to you 25 times over two years after final (stage three) FDA approval of Grazoph. That's 2500% return in an estimated five to seven years.

This is a completely new business model for a very lucrative market. Virtually no other company has received FDA approval for a unique combination of herbs to significantly treat a major disease. By receiving federal approval of our unique products, we raise ourselves apart from the vast majority of other herbal products companies in the field of consumer medicine.

By keeping the formulas trade secrets we may invite copycat companies which will probably erode our market share over time. But the ticking clock counting down the expiration of patents will never come into play. Thus, branding becomes important in the long run. We will always hold that trump card by being the originators. The pharmaceutical pipeline is fairly dry, having mined and piped all the reasonably attainable drugs. Yet the modern science of complex herbal formulas has only started. Consumers will believe us once we have FDA approval.

This investment opportunity is not forever as our offered return rate will steadily decrease as documentation of the effectiveness and safety of our products grows and as more investors join us.

Our first market is China with its significantly lower barriers to entry and much different and more positive acceptance of herbal medicine. We plan to use the profits from China sales to fund U.S. clinical trials. But first we require larger production machinery.

Call us or email us with REQUEST BUSINESS PLAN in the subject line to learn more about this incredible profit opportunity while doing something to improve the lives of many.